Skip to main content
. 2020 Feb 6;9(2):442. doi: 10.3390/jcm9020442

Table 4.

Univariate regression of adherence to PAP therapy.

Device Type Adjusted OR (95% CI) p-Value
Median Income * p < 0.0001
Low ($40,834–50,366) 1.19 (1.15, 1.22)
High ($50,376–65,143) 1.27 (1.23, 1.30)
Highest ($65,150–223,106) 1.35 (1.31, 1.39)
Age 1.01 (1.01, 1.01) p < 0.0001
Women 1.00 (1.00, 1.00) p < 0.0001
African American race 0.99 (0.99, 0.99) p < 0.0001
Hispanic ethnicity 0.99 (0.99, 0.99) p < 0.0001
Average leak > 45 lpm 0.76 (0.75, 0.78) p < 0.0001
Device type p < 0.0001
Bilevel PAP 0.87 (0.83, 0.91)
AutoPAP 1.05 (1.03, 1.07)
AutoBilevelPAP 0.83 (0.79, 0.86)
ASV 0.68 (0.63, 0.74)
AVAPS 0.30 (0.23, 0.38)
High altitude elevation p < 0.0001
2000–4000 feet 1.06 (1.01, 1.12)
4001–6000 feet 1.24 (1.16, 1.32)
>6000 feet 1.15 (1.02, 1.31)
Residual CAI > 5/hour 0.59 (0.55, 0.63) p < 0.0001
Residual AHI > 5/hour 0.62 (0.61, 0.64) p < 0.0001
Set-up year p < 0.0001
Quartile 2 (2011–2012) 1.39 (1.35, 1.42)
Quartile 3 (2013–2014) 1.61 (1.57, 1.66)
Quartile 4 (>2015) 1.80 (1.75, 1.85)

OR = odds ratio; 95%CI = 95% confidence interval; * reference is Quartile 1 (lowest income quartile; <$40,834); ANOVA p-value < 0.0001; lpm = liters per minute; referenced against CPAP; automatic devices (autoPAP, auto-bilevel PAP, adaptive servo-ventilation (ASV), adaptive volume averaged pressure support (AVAPS)). † High elevation (referenced against < 2000 feet); CAI = central apnea index; AHI = apnea–hypopnea index. Reference earliest quartile of time (in years) of set-up is < 2011.